Mochi Founder & CEO Dr. Myra Ahmad - How GLP-1s Are Transforming Healthcare

Dr. Myra Ahmad, Founder & CEO of Mochi, joins Clint Betts for a conversation on obesity medicine, GLP-1 medications, telehealth, healthcare innovation, and the future of personalized metabolic care.

Mochi is building a marketplace for evidence-based healthcare, helping patients connect with providers for customized treatment plans focused on obesity, metabolic health, menopause care, skincare, and more. In this episode, Dr. Ahmad explains why GLP-1 medications like Ozempic and Wegovy are fundamentally changing healthcare — and why obesity should be treated like any other chronic medical condition.

The conversation also explores telemedicine, personalized medicine, healthcare costs, startup culture, compounding pharmacies, and the growing role of technology in healthcare delivery.

00:00:00 - Introduction and Welcome
00:00:13 - What is Mochi?
00:00:31 - Revolution in Metabolic Health
00:01:01 - Mochi's Unique Approach
00:01:48 - Future of Healthcare
00:02:11 - Dr. Ahmad's Background and Inspiration
00:02:33 - The Obesity Epidemic
00:03:37 - Factors Contributing to Obesity
00:04:12 - Socioeconomic Factors in Obesity
00:05:02 - Government and Food Industry's Role
00:05:24 - Decline in Obesity Rates
00:05:55 - Anti-GLP-1 Sentiment
00:06:19 - Medication Management and Supervision
00:07:29 - Personalized Medication and Compounding
00:08:28 - Understanding Compounded GLP-1s
00:09:47 - Future of Personalized Medication
00:10:17 - Why Drugs are Expensive
00:11:27 - A Day in the Life of a CEO
00:12:05 - Funding and Profitability
00:12:24 - Competitive Landscape
00:13:18 - Building the Team and Culture
00:13:37 - Advantages of Starting in San Francisco
00:14:03 - Startup Culture in San Francisco
00:14:55 - Reading Recommendations for CEOs
00:15:29 - Regulatory Hurdles in Health Tech
00:16:40 - Transition from Medicine to Startup
00:17:42 - Impact of Being an MD
00:18:29 - Macroeconomic Environment
00:19:45 - Political Impact on Healthcare
00:20:49 - Final Question: Who Gave You a Chance?
00:21:21 - Closing Remarks and Future Plans

If you’re interested in healthcare, startups, telemedicine, GLP-1s, entrepreneurship, or the future of metabolic medicine, this conversation is packed with insights on where healthcare is heading next.

Subscribe for more conversations with founders, CEOs, and leaders shaping the future of business and technology.